Changeflow GovPing Healthcare & Life Sciences Bacteriophage Patent, Bacterial Wilt Control, P...
Routine Notice Added Final

Bacteriophage Patent, Bacterial Wilt Control, PANEFRI, Apr 14

Favicon for changeflow.com USPTO Patent Grants - Biotech (C12N)
Published
Detected
Email

Summary

USPTO granted Patent US12599142B2 to PANEFRI INDUSTRIAL CO., LTD. on April 14, 2026, covering bacteriophages comprising a tail fiber protein with a C terminus host recognition site (SEQ ID NO: 1) that infect Ralstonia solanacearum, the pathogen causing bacterial wilt disease in plants. The patent contains 20 claims and protects compositions and methods for preventing or treating bacterial wilt disease in a wide variety of plant hosts.

“Bacteriophages that comprise a tail fiber protein sequence comprising a C terminus host recognition site described by SEQ ID NO: 1 and which infect Ralstonia solanacearum which causes bacterial wilt disease are disclosed.”

USPTO , verbatim from source
Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors USPTO Patent Grants - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 16 changes logged to date.

What changed

USPTO granted Patent US12599142B2 to PANEFRI INDUSTRIAL CO., LTD., covering bacteriophages with a tail fiber protein sequence comprising a C terminus host recognition site described by SEQ ID NO: 1 that infect Ralstonia solanacearum, the causative agent of bacterial wilt disease. The patent protects compositions comprising these bacteriophages as wilt control agents and methods for preventing or treating bacterial wilt disease in plants.

For parties interested in agricultural biocontrol, plant pathology, or crop protection technology, this grant establishes enforceable intellectual property rights in the United States for phage-based bacterial wilt disease control. The patent's broad claim scope covering methods for preventing or treating diseases caused by Ralstonia solanacearum may affect research, product development, and licensing discussions in the agricultural biocontrol space.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Bacteriophage, bacterial wilt disease control agent, and bacterial wilt disease control method

Grant US12599142B2 Kind: B2 Apr 14, 2026

Assignee

PANEFRI INDUSTRIAL CO., LTD.

Inventors

Toshiaki Harashima, Kazuma Nakano, Toru Karimata, Kumiko Hokama

Abstract

Bacteriophages that comprise a tail fiber protein sequence comprising a C terminus host recognition site described by SEQ ID NO: 1 and which infect Ralstonia solanacearum which causes bacterial wilt disease are disclosed. Compositions comprising these bacteriophages may be employed as wilt control agents. Methods for preventing or treating diseases caused by Ralstonia solanacearum such as bacterial wilt disease are also disclosed. A bacterial wilt disease control method in a plant may include administering such bacteriophages to a plant or to a plant growth medium and can be effective against a wide variety of Ralstonia solanacearum strains. Nucleic acids encoding the C terminus host recognition site and amino acid sequences comprising the host recognition site are also disclosed.

CPC Classifications

A01N 63/40 A01P 1/00 A01P 3/00 C07K 14/005 C07K 14/01 C12N 7/00 C12N 2795/10221 C12N 2795/10222 C12N 2795/10232 C12N 2795/10271

Filing Date

2020-07-30

Application No.

18007432

Claims

20

View original document →

Get daily alerts for USPTO Patent Grants - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 14th, 2026
Instrument
Notice
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12599142B2

Who this affects

Applies to
Manufacturers
Industry sector
1111 Crop Production
Activity scope
Patent grant IP licensing Biocontrol development
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Agriculture Public Health

Get alerts for this source

We'll email you when USPTO Patent Grants - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!